The FDA's breakthrough and fast-track designations reduced the average time it takes to bring a drug to market by about a year or more, three health economists assert in a JAMA article.
Breakthrough status accelerates drug development
Sign up for Specialty Pharmacy SmartBrief
News affecting the specialty pharmacy industry
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.